Therapeutic Targeting of the Tumor Microenvironment

Leire Bejarano1, Marta J C Jordāo1, Johanna A Joyce2,3

  • 1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

Cancer Discovery
|April 3, 2021
PubMed

Insights

Targeting the tumor microenvironment (TME) offers a promising cancer treatment strategy. This review covers advanced TME therapies, including immunotherapies and antiangiogenic drugs, alongside challenges and future directions.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • The tumor microenvironment (TME) critically influences tumor progression and treatment response.
  • Targeting the TME is a rapidly advancing area in cancer therapy.
  • Understanding TME components is key to developing effective treatments.

Purpose of the Study:

  • To review current knowledge on advanced therapies targeting the tumor microenvironment.
  • To discuss clinically approved and investigational TME-directed treatments.
  • To explore challenges and future perspectives in TME-targeted cancer therapy.

Main Methods:

  • Comprehensive literature review of TME-directed therapies.
  • Analysis of immunotherapies, antiangiogenic drugs, and treatments targeting cancer-associated fibroblasts and extracellular matrix.
  • Evaluation of clinical trial data and basic science principles.

Main Results:

  • Several TME-directed therapies, including immunotherapies and antiangiogenic agents, are in clinical use or trials.
  • Treatments targeting cancer-associated fibroblasts and the extracellular matrix show therapeutic potential.
  • Significant progress has been made in understanding TME biology and its therapeutic implications.

Conclusions:

  • Targeting the tumor microenvironment represents a significant frontier in cancer treatment.
  • Further research is needed to overcome challenges and optimize TME-directed therapies.
  • Future strategies will likely involve combination therapies and novel approaches to modulate the TME.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
818
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K